240 related articles for article (PubMed ID: 30142194)
1. The uterine epithelial loss of Pten is inefficient to induce endometrial cancer with intact stromal Pten.
Liang X; Daikoku T; Terakawa J; Ogawa Y; Joshi AR; Ellenson LH; Sun X; Dey SK
PLoS Genet; 2018 Aug; 14(8):e1007630. PubMed ID: 30142194
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus mediated homozygous endometrial epithelial Pten deletion results in aggressive endometrial carcinoma.
Joshi A; Ellenson LH
Exp Cell Res; 2011 Jul; 317(11):1580-9. PubMed ID: 21397598
[TBL] [Abstract][Full Text] [Related]
3. [Immunomorphologic features of epithelial-stromal relationships at hyperplasia and endometrial carcinoma].
Bantysh BB; Paukov vS; Kogan EA
Arkh Patol; 2012; 74(3):22-5. PubMed ID: 22937575
[TBL] [Abstract][Full Text] [Related]
4. Cell-specific conditional deletion of Pten in the uterus results in differential phenotypes.
Daikoku T; Jackson L; Besnard V; Whitsett J; Ellenson LH; Dey SK
Gynecol Oncol; 2011 Aug; 122(2):424-9. PubMed ID: 21570712
[TBL] [Abstract][Full Text] [Related]
5. Mutual contribution of Pten and estrogen to endometrial carcinogenesis in a PtenloxP/loxP mouse model.
Saito F; Tashiro H; To Y; Ohtake H; Ohba T; Suzuki A; Katabuchi H
Int J Gynecol Cancer; 2011 Nov; 21(8):1343-9. PubMed ID: 21989218
[TBL] [Abstract][Full Text] [Related]
6. Stromal liver kinase B1 [STK11] signaling loss induces oviductal adenomas and endometrial cancer by activating mammalian Target of Rapamycin Complex 1.
Tanwar PS; Kaneko-Tarui T; Zhang L; Tanaka Y; Crum CP; Teixeira JM
PLoS Genet; 2012; 8(8):e1002906. PubMed ID: 22916036
[TBL] [Abstract][Full Text] [Related]
7. Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice.
Daikoku T; Hirota Y; Tranguch S; Joshi AR; DeMayo FJ; Lydon JP; Ellenson LH; Dey SK
Cancer Res; 2008 Jul; 68(14):5619-27. PubMed ID: 18632614
[TBL] [Abstract][Full Text] [Related]
8. An inducible knockout mouse to model the cell-autonomous role of PTEN in initiating endometrial, prostate and thyroid neoplasias.
Mirantes C; Eritja N; Dosil MA; Santacana M; Pallares J; Gatius S; Bergadà L; Maiques O; Matias-Guiu X; Dolcet X
Dis Model Mech; 2013 May; 6(3):710-20. PubMed ID: 23471917
[TBL] [Abstract][Full Text] [Related]
9. Glandular epithelial AR inactivation enhances PTEN deletion-induced uterine pathology.
Choi JP; Zheng Y; Handelsman DJ; Simanainen U
Endocr Relat Cancer; 2016 May; 23(5):377-90. PubMed ID: 26984887
[TBL] [Abstract][Full Text] [Related]
10. Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer.
Kim TH; Lee DK; Cho SN; Orvis GD; Behringer RR; Lydon JP; Ku BJ; McCampbell AS; Broaddus RR; Jeong JW
Cancer Res; 2013 Aug; 73(16):5090-9. PubMed ID: 23811943
[TBL] [Abstract][Full Text] [Related]
11. Cell-autonomous activation of the PI3-kinase pathway initiates endometrial cancer from adult uterine epithelium.
Memarzadeh S; Zong Y; Janzen DM; Goldstein AS; Cheng D; Kurita T; Schafenacker AM; Huang J; Witte ON
Proc Natl Acad Sci U S A; 2010 Oct; 107(40):17298-303. PubMed ID: 20855612
[TBL] [Abstract][Full Text] [Related]
12. Conditional abrogation of transforming growth factor-β receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice.
Gao Y; Lin P; Lydon JP; Li Q
J Pathol; 2017 Sep; 243(1):89-99. PubMed ID: 28657664
[TBL] [Abstract][Full Text] [Related]
13. Uterine epithelial cell proliferation and endometrial hyperplasia: evidence from a mouse model.
Gao Y; Li S; Li Q
Mol Hum Reprod; 2014 Aug; 20(8):776-86. PubMed ID: 24770950
[TBL] [Abstract][Full Text] [Related]
14. Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.
Mu X; Pradere JP; Affò S; Dapito DH; Friedman R; Lefkovitch JH; Schwabe RF
Gastroenterology; 2016 Mar; 150(3):720-33. PubMed ID: 26627606
[TBL] [Abstract][Full Text] [Related]
15. Neonatal estrogenic exposure suppresses PTEN-related endometrial carcinogenesis in recombinant mice.
Begum M; Tashiro H; Katabuchi H; Suzuki A; Kurman RJ; Okamura H
Lab Invest; 2006 Mar; 86(3):286-96. PubMed ID: 16402032
[TBL] [Abstract][Full Text] [Related]
16. Effect of asoprisnil on uterine proliferation markers and endometrial expression of the tumour suppressor gene, PTEN.
Wilkens J; Williams AR; Chwalisz K; Han C; Cameron IT; Critchley HO
Hum Reprod; 2009 May; 24(5):1036-44. PubMed ID: 19176543
[TBL] [Abstract][Full Text] [Related]
17. Loss of CDH1 and Pten accelerates cellular invasiveness and angiogenesis in the mouse uterus.
Lindberg ME; Stodden GR; King ML; MacLean JA; Mann JL; DeMayo FJ; Lydon JP; Hayashi K
Biol Reprod; 2013 Jul; 89(1):8. PubMed ID: 23740945
[TBL] [Abstract][Full Text] [Related]
18. Endometrial stromal beta-catenin is required for steroid-dependent mesenchymal-epithelial cross talk and decidualization.
Zhang L; Patterson AL; Zhang L; Teixeira JM; Pru JK
Reprod Biol Endocrinol; 2012 Sep; 10():75. PubMed ID: 22958837
[TBL] [Abstract][Full Text] [Related]
19. Activated mutant p110α causes endometrial carcinoma in the setting of biallelic Pten deletion.
Joshi A; Miller C; Baker SJ; Ellenson LH
Am J Pathol; 2015 Apr; 185(4):1104-13. PubMed ID: 25698082
[TBL] [Abstract][Full Text] [Related]
20. Glucose-regulated protein 94 deficiency induces squamous cell metaplasia and suppresses PTEN-null driven endometrial epithelial tumor development.
Shen J; Yao L; Lin YG; DeMayo FJ; Lydon JP; Dubeau L; Lee AS
Oncotarget; 2016 Mar; 7(12):14885-97. PubMed ID: 26910913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
